1 |
JEMAL A,BRAY F,CENTER MM,et al.Global cancer statistics[J]. CA Cancer J Clin,2011,61(2):69-90.
|
2 |
MU J,ZUO Y,YANG W,et al.Over-expression of small ubiquitin-like modifier proteases 1 predicts chemo-sensitivity and poor survival in non-small cell lung cancer[J]. Chin Med J(Engl),2014,127(23):4060-4065.
|
3 |
WANG M,WANG J,DENG J,et al.MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer[J]. Med Oncol,2015,32(1):344.
|
4 |
LIU G,XU S,JIAO F,et al.Vascular endothelial growth factor B coordinates metastasis of non-small cell lung cancer[J]. Tumour Biol,2015,36(3):2185-2191.
|
5 |
WAMSLEY JJ,KUMAR M,ALLISON DF,et al.Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer[J]. Cancer Res,2015,75(2):426-435.
|
6 |
SONG Q,XU Y,YANG C,et al.miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM[J]. Cancer Res,2014,74(11):3031-3042.
|
7 |
GENG Q,FAN T,ZHANG B,et al.Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer[J]. Respir Res,2014,15:149.
|
8 |
LI Y,LI W,OUYANG Q,et al.Detection of lung cancer with blood microRNA-21 expression levels in Chinese population[J]. Oncol Lett,2011,2(5):991-994.
|
9 |
HOU JM,KREBS M,WARD T,et al.Circulating tumor cells as a window on metastasis biology in lung cancer[J]. Am J Pathol,2011,178(3):989-996.
|
10 |
周沐青,刘鷖雯,王颖智,等. 荧光定量PCR检测VEGF-C、CEACAM-1在胃肠肿瘤中的表达及意义[J]. 检验医学,2011,26(5):299-305.
|
11 |
IRANPARAST S,ASSAREHZADEGAN MA,HEIKE Y,et al.Wilms' tumor gene(WT1) expression correlates with vascular epithelial growth factor(VEGF) in newly acute leukemia patients undergoing chemotherapy[J]. Asian Pac J Cancer Prev,2014,15(21):9217-9223.
|
12 |
LI J,HU YM,DU YJ,et al.Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer[J]. BMC Cancer,2014,14:848.
|
13 |
DA MX,ZHANG YB,YAO JB,et al.DNA methylation regulates expression of VEGF-C,and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth[J]. Braz J Med Biol Res,2014,47(12):1021-1028.
|
14 |
王敏. 血清VEGF、TGF-β1及内皮抑素在非小细胞肺癌中的表达及相关性研究[J]. 检验医学,2013,28(8):676-680.
|
15 |
TOOMEY D,SMYTH G,CONDRON C,et al.Immune function,telomerase,and angiogenesis in patients with primary,operable nonsmall cell lung carcinoma:tumor size and lymph node status remain the most important prognostic features[J]. Cancer,2001,92(10):2648-2657.
|
16 |
TABERNERO J.The role of VEGF and EGFR inhibition:implications for combining anti-VEGF and anti-EGFR agents[J]. Mol Cancer Res,2007,5(3):203-220.
|
17 |
郭光祖,徐洪波. 血清VEGF和EGF检测对肺癌患者的临床意义[J]. 中国医药指南,2009,7(5):32-33.
|
18 |
YUAN A,YU CJ,CHEN WJ,et al.Correlation of total VEGF mRNA and protein expression with histologic type,tumor angiogenesis,patient survival and timing of relapse in non-small-cell lung cancer[J]. Int J Cancer,2000,89(6):475-483.
|
19 |
孙杰,吴斌,梁标. VEGF在非小细胞肺癌中的表达及对预后的影响[J]. 实用医技杂志,2006,13(10):1733-1734.
|
20 |
申培红,申培新,吕新泉,等. 血管内皮生长因子、上皮性钙黏蛋白、基质金属蛋白酶在乳腺肿瘤中的表达及其与浸润转移的关系[J]. 中华实用诊断与治疗杂志,2009,23(3):250-252.
|